Journal of Antivirals & Antiretrovirals
Open Access

Abstract

Seroprevalence of Antivirals and Risks of Acquiring among Quarantined Individuals in North West Ethiopia: A Survey Study

Fassikaw Kebede, Tsehay Kebede, Birhanu Kebede and Agumas Fentahun Ayalew*

Novel coronavirus 2019 (COVID-19) is a worldwide spreading pandemic respiratory disease caused by a positive single strand (RNA) virus. The efforts for preventing COVID-19 pandemic remain fruitless and ineffective. So this study aims to assess Seroprevalence, Knowledge and Practice of COVID-19 prevention among quarantined individual in North West Ethiopia.

Methods: Institutional-based survey was conducted on COVID-19 suspected quarantined individuals from 21 April-30 December 2020. The collected data were edited and enter into EPI-DATA 3.1 version, then export to STATA/R-14 (SE) software for analysis.

Results: Of 4233 quarantined individuals who received the SARS-CoV-2 IgG antibody test, 4230/99.78% were interviewed with a 99.82% response rate. The overall seroprevalence of COVID-19 symptom suspected quarantined individuals in North West Ethiopia was found 5.11, 95% CI (4.4-5.87). The overall knowledge and practice of prevention towards COVID-19 infection on isolated individuals were found 86.17 %( 95%CI: 85.1-87.2), and 62.82%; 95% CI: 60.75-63.8).

Conclusion: The sero-prevalence of the quarantined population was high as compared with previously reported. The majority of the respondents know how to prevent themselves from the COVID-19, but changing this prevention knowledge into the practice of tackling was great gap.

Published Date: 2021-08-30; Received Date: 2021-08-09